Showing posts with label CAS NO 1018899-04-1. Show all posts
Showing posts with label CAS NO 1018899-04-1. Show all posts

Thursday, May 23, 2024

High Purity 99.6% Sotagliflozin LX-4211 for heart failure or diabetes CAS NO 1018899-04-1 Pharmaceutical Intermediate

 

Introduction of Sotagliflozin LX-4211.

Sotagliflozin is a medication used to treat adults with type 1 diabetes mellitus. It's an oral medication that works by inhibiting two proteins involved in glucose regulation: SGLT1 and SGLT2. By inhibiting these proteins, sotagliflozin helps to lower blood sugar levels in people with type 1 diabetes, particularly when used alongside insulin therapy.